Immuno-Biological Laboratories Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 29.55% vs -26.92% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 32.51% vs -47.36% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.00",
          "val2": "211.50",
          "chgp": "29.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "92.30",
          "val2": "58.60",
          "chgp": "57.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.40",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "80.70",
          "val2": "60.90",
          "chgp": "32.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "320.10%",
          "val2": "257.30%",
          "chgp": "6.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 33.37% vs 164.45% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "969.50",
          "val2": "816.70",
          "chgp": "18.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "224.80",
          "val2": "113.30",
          "chgp": "98.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "1.10",
          "chgp": "18.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "-0.50",
          "chgp": "180.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "249.00",
          "val2": "186.70",
          "chgp": "33.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.90%",
          "val2": "135.90%",
          "chgp": "8.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

274.00

211.50

29.55%

Operating Profit (PBDIT) excl Other Income

92.30

58.60

57.51%

Interest

0.30

0.40

-25.00%

Exceptional Items

0.00

5.30

-100.00%

Consolidate Net Profit

80.70

60.90

32.51%

Operating Profit Margin (Excl OI)

320.10%

257.30%

6.28%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 29.55% vs -26.92% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 32.51% vs -47.36% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

969.50

816.70

18.71%

Operating Profit (PBDIT) excl Other Income

224.80

113.30

98.41%

Interest

1.30

1.10

18.18%

Exceptional Items

0.40

-0.50

180.00%

Consolidate Net Profit

249.00

186.70

33.37%

Operating Profit Margin (Excl OI)

215.90%

135.90%

8.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 18.71% vs 2.78% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 33.37% vs 164.45% in Mar 2024

All Annual Results